BioWorld Asia

Sep. 11, 2002

View Archived Issues

Kudos Raises £30M For Clinical Development Of Cancer Drugs

LONDON - Kudos Pharmaceuticals Ltd. raised £29.5 million (US$45.9 million) in third-round funding with plans to take its two lead cancer treatments through Phase II and push further compounds into Phase I. (Bioworld International Read More

With New Premises, Tropos Launches € 15M Funding Round

No Abstract Read More

Gene Deletion From Colorectal Tumors Might Dictate Success

Read More

Session Examines Avoiding Legal Pitfalls In Clinical Trials

Read More

Committee Provides Support For European Biotechnology

Read More

EU Legislation On GMO Exports Weak, Parliament Member Says

Read More

Medivir To Lose CEO Frick To Venture Capital Fund

Read More

MediGene Reports Positive Early Results In Liver Cancer

Read More

Avidex Third Round Raises £11.5M For T-Cell Receptors

Read More

New Controls On Genetically Modified Animals Needed In UK

Read More

ScanBalt BioRegion Looking To Create Global Biotech Region

Read More

Other News To Note

Read More